Institutional investors control 47.96% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2015, these large investors purchased a net $518.6 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NEW JERSEY DIVISION OF INVESTMEN... Bought 975.0 Thousand shares of Geron Corp
CITADEL ADVISORS LLC Bought 634.4 Thousand shares of Geron Corp